Roche and Takeda have announced that they will be using organ-chip technology in their R&D Programs through partnerships with Emulate, the biotech startup behind organs-on-a-chip.
Emulate and Roche have formed a three-year partnership to use organ-chips for testing the efficacy and safety of new antibody therapeutics and combination therapies.
Working in a jointly-run lab, researchers hope to use the chips to gain further insight into disease mechanisms and to increase predictability and early detection of biomarkers.
The collaboration will initially use lung-chips and brain-chips with the possibility of using other organ-chips.
The partnership with Takeda will use Emulate’s intestine-chip in the R&D of drugs to treat gastrointestinal (GI) diseases.
The intestine-chip can be used to recreate the mechanisms of the intestinal lining, which is understood to be associated with many GI diseases.
Register as Visitor to CPhI China 2018!
(All Rights Reserved)